Trials / Completed
CompletedNCT05902364
Systane® Ultra Preservative Free Lubricant Eye Drops
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 69 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this post-market clinical follow-up (PMCF) study is to assess the performance and safety of Systane Ultra Preservative-Free (PF) in subjects experiencing dry eye symptoms (Group 1) and contact lens (CL) wearers experiencing discomfort due to CL-related dryness (Group 2). Statistical analyses will be presented by group. This study will be conducted in Canada, Australia, and New Zealand.
Detailed description
Subjects will participate in the study for approximately 30 days, with a phone call scheduled on Day 15 ± 2 (Visit 2) and a follow-up visit scheduled on Day 30 ± 2 (Visit 3). Subjects will be asked to complete patient questionnaires on Day 1 and at Visit 3 (Impact of Dry Eye on Everyday Life - Symptom Bother \[IDEEL-SB\] or Contact Lens Dry Eye Questionnaire \[CLDEQ-8\] and Comfortable Wear Time questions).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Systane Ultra PF lubricant eye drops | Commercially available preservative free eye drops |
Timeline
- Start date
- 2023-10-28
- Primary completion
- 2024-08-14
- Completion
- 2024-08-14
- First posted
- 2023-06-15
- Last updated
- 2025-08-27
- Results posted
- 2025-08-27
Locations
4 sites across 2 countries: Canada, New Zealand
Source: ClinicalTrials.gov record NCT05902364. Inclusion in this directory is not an endorsement.